Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Modifiers of 22q11.2 Deletion Syndrome

NCT00556530 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.

NCT NCT00556530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00556530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Modifiers of 22q11.2 Deletion Syndrome
Lead sponsor
Albert Einstein College of Medicine
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2016
Completion date
June 30, 2029
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

22q11.2 deletion syndrome, digeorge syndrome